Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer
Acta Biochimica et Biophysica Sinica · 2023
DOI: 10.3724/abbs.2023160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Jia Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hebei Medical University, Shijiazhuang 050017, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Hebei Medical University, Shijiazhuang 050017, China.
- Department of Hematology, Affiliated Hospital of Hebei University, Baoding 071000, China.
- Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang 050082, China.
- Department of Oncology, Hebei General Hospital, Shijiazhuang 050057, China.
- Beijing Sunbio Biotech Co., Ltd., Beijing 100000, China.
- Department of Immunology, Hebei Medical University, Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang 050017, China.
Zitieren
APA
Liu, J., Zhu, T., Liu, J., Cui, Y., Yang, S., & Zhao, R. (2023). Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023160
Vancouver
Liu J, Zhu T, Liu J, Cui Y, Yang S, Zhao R. Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023160
BibTeX
@article{Liu2023,
author = {Liu, Jia and Zhu, Tienian and Liu, Jiankun and Cui, Yujie and Yang, Shifang and Zhao, Ruijing},
title = {Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2023},
doi = {10.3724/abbs.2023160}
}
EUVIMED